Highlights • Frequency of anti-tumor CD8 T cells at baseline in blood predicts anti-PD-1 response • Frequency of anti-tumor CD8 T cells in the tumor does not predict anti-PD-1 response • Intratumoral CD8 T cells are more dysfunctional than their peripheral counterparts • HLA-I downregulation is a mechanism of secondary resistance to anti-PD-1 in MCC Summary Understanding cancer immunobiology has been hampered by difficulty identifying cancer-specific T cells.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Lichen
Contact Lichen, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack